New Sirio Institute for Anti-Aging created by Sirio aims to advance anti-aging science

Image | adobe.stock/Yuliia

In a recent press release, Sirio Pharma (Sirio), a global nutraceutical contract development and manufacturing organization (CDMO), announced the creation of the Sirio Institute for Anti-Aging (SIA) at the 2025 Boao Health Food Science Conference and Expo. The hope of this new venture is to help move anti-aging science forward and hasten the development of nutraceutical products. SIA plans on offering customers with a variety of tools such as support, resources, and knowledge so that new anti-aging offerings can be brought to market.

The new research institute will look into four core areas: probiotics and gut health, cellular health, reproductive system health, and muscle health. A global Scientific Advisory Board consisting of experts in the industry will oversee SIA. The press release mentions that Dr. Yu-Xuan Lyu, research assistant professor at the Institute of Advanced Biotechnology and the School of Medicine at the Southern University of Science and Technology (SUSTech), will lead SIA and organize the Scientific Advisory Board. “With global populations rapidly greying, the demand for scientifically validated nutraceuticals that can delay or minimize the unwanted effects of aging has reached unprecedented levels. Yet many products on the market today frequently promote safety and efficacy claims lacking robust scientific and clinical evidence,” said Dr. Lyu. “The Sirio Institute for Anti-Aging (SIA) will pioneer rigorous, evidence-based research and product development for our nutraceutical partners worldwide. Our approach extends beyond merely delaying aging manifestations, aiming to identify and the modulate fundamental mechanisms of aging. We will conduct cutting-edge research into innovative bioactive ingredients, synergistic formulations, delivery and stability optimization protocols, and demonstrable consumer health benefits.”

Dr. Youyou Zhao, assistant vice president of Sirio, global head of research and development, and chief scientist, commented, “We are committed to creating verifiable, traceable, and scientifically applicable evidence-based solutions for anti-aging. The establishment of the SIA represents a significant leap in SIRIO’s R&D capabilities and our innovative transformation. By integrating cutting-edge global anti-aging research with valuable consumer insights and industrial applications, we aim to enhance product value and explore new market opportunities. So that our brand partners can move ahead of the big trends of tomorrow, and most importantly deliver nutraceuticals that have best in class organoleptic properties combined with proven real-world efficacy.”